Back to News
Market Impact: 0.3
Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates
Source: zacks.com
Corporate EarningsCompany FundamentalsAnalyst EstimatesHealthcare & Biotech
Gilead Sciences reported quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.17 by $0.38, or about 17.5%. Earnings were up from $2.47 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
GILD0.55
More News
- Our AI knew it: +72%, +60%, +59% - these picks are still climbing into Q3 results
- Gilead earnings on deck: Can pipeline wins offset acquisition costs?
- What Gilead Sciences (GILD) Said on Its Q3 Earnings Call
- Cognizant Reports Third Quarter 2026 Results
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search